PrescriberPoint News

How a Cardio-Metabolic Brand Cut Prescription Denials 25% with Coverage Intelligence

Written by PrescriberPoint Team | May 19, 2026 1:11:59 PM
The brand had strong formulary coverage. Prescribers just couldn't see it when it
mattered.
The Problem

The brand had broad formulary coverage and a strong clinical profile. But prescribers
weren't seeing that coverage data at the moment they were choosing a therapy.

Coverage information was scattered across payer portals, formulary databases, and rep conversations. By the time a prescriber learned the drug was covered at a favorable tier, they'd already written for something else — or the patient had received a denial.

The brand was paying for formulary access that wasn't converting into prescriptions.

Campaign Snapshot
What they did

Through PrescriberPoint, the brand surfaced plan-specific coverage data, tier status,
and PA requirements directly to their target HCPs — inside the prescribing workflow,
not after it.

PrescriberPoint's AI layer matches the drug against each patient's specific payer plan in real time. No rep visit required. No portal to check. The coverage answer appears at the point of care, before the prescription is written.

The goal was simple: give prescribers the full picture — clinical evidence, patient cost,
and plan coverage — so they make a complete decision the first time.

The Results

 

Why It Matters

Every therapeutic area has the same gap. Brands invest in formulary access, but that
access is invisible to prescribers at the moment of decision.

The brands that close this gap convert more of their coverage investment into actual
prescriptions. Fewer denials. Faster time to therapy. Higher ROI on every dollar spent
earning formulary position.